New data from a 20-year follow-up of patients with ER-positive/HER2-negative breast cancer identifies those who have lasting benefit from tamoxifen.
Medscape Medical News
Twenty Years and Counting: Tamoxifen Benefit in Breast Cancer
New data from a 20-year follow-up of patients with ER-positive/HER2-negative breast cancer identifies those who have lasting benefit from tamoxifen.
Medscape Medical News
